ArticleThe Journal of antimicrobial chemotherapy2016

Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia.

Monika Kumaraswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.